Insider Transactions in Q2 2022 at Kempharm, Inc (KMPH)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 25
2022
|
David S Tierney Director |
BUY
Open market or private purchase
|
Direct |
2,000
+25.53%
|
$8,000
$4.39 P/Share
|
|
May 25
2022
|
Travis C Mickle President & CEO |
BUY
Open market or private purchase
|
Indirect |
10,000
+47.54%
|
$40,000
$4.39 P/Share
|
|
May 25
2022
|
Travis C Mickle President & CEO |
BUY
Open market or private purchase
|
Direct |
3,000
+3.7%
|
$12,000
$4.37 P/Share
|
|
May 20
2022
|
Tamara A Seymour Director |
BUY
Open market or private purchase
|
Direct |
200
+50.0%
|
$800
$4.87 P/Share
|
|
May 18
2022
|
R. La Duane Clifton CFO & Treasurer |
BUY
Open market or private purchase
|
Direct |
1,200
+15.71%
|
$6,000
$5.0 P/Share
|
|
May 18
2022
|
Richard W Pascoe Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+10.14%
|
$20,000
$4.92 P/Share
|
|
May 18
2022
|
Matthew R Plooster Director |
BUY
Open market or private purchase
|
Direct |
5,000
+17.57%
|
$20,000
$4.96 P/Share
|